105 related articles for article (PubMed ID: 28697187)
1. Can semiquantitative measurements of SUVmax and cut-off values differentiate colorectal malignant from benign lessions?
Nguyen T; Hess S; Petersen H; Alavi A; Høilund-Carlsen PF
Hell J Nucl Med; 2017; 20(2):113-121. PubMed ID: 28697187
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
3. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of incidental focal bowel uptake on
Soltau SR; Hess S; Nguyen T; Gerke O; Petersen H; Alavi A; Høilund-Carlsen PF
Hell J Nucl Med; 2016; 19(3):245-249. PubMed ID: 27824964
[TBL] [Abstract][Full Text] [Related]
5. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
Akamatsu G; Ikari Y; Nishida H; Nishio T; Ohnishi A; Maebatake A; Sasaki M; Senda M
J Nucl Med Technol; 2015 Sep; 43(3):222-6. PubMed ID: 26271802
[TBL] [Abstract][Full Text] [Related]
6. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
7. JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.
Marcus C; Wray R; Taghipour M; Marashdeh W; Ahn SJ; Mena E; Subramaniam RM
AJR Am J Roentgenol; 2016 Aug; 207(2):257-65. PubMed ID: 27447341
[TBL] [Abstract][Full Text] [Related]
8. Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters.
Lee H; Hwang KH; Kwon KA
World J Clin Cases; 2022 Jun; 10(17):5634-5645. PubMed ID: 35979099
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Endometrial Cancer: A Retrospective Study.
Lund AA; Vilstrup MH; Jochumsen KM; Hess S
Int J Gynecol Cancer; 2017 Oct; 27(8):1675-1684. PubMed ID: 28832352
[TBL] [Abstract][Full Text] [Related]
10. Tumor metabolism measured by partial volume corrected standardized uptake value varies considerably in primary and metastatic sites in patients with lung cancer. A new observation.
Bural G; Torigian DA; Houseni M; Basu S; Srinivas S; Alavi A
Hell J Nucl Med; 2009; 12(3):218-22. PubMed ID: 19936331
[TBL] [Abstract][Full Text] [Related]
11. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
12. The value of
Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
[TBL] [Abstract][Full Text] [Related]
13. Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.
Brendle C; Kupferschläger J; Nikolaou K; la Fougère C; Gatidis S; Pfannenberg C
Eur J Radiol; 2015 Jan; 84(1):158-162. PubMed ID: 25467224
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
Zaizen Y; Azuma K; Kurata S; Sadashima E; Hattori S; Sasada T; Imamura Y; Kaida H; Kawahara A; Kinoshita T; Ishibashi M; Hoshino T
Eur J Radiol; 2012 Dec; 81(12):4179-84. PubMed ID: 22884163
[TBL] [Abstract][Full Text] [Related]
15. Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.
Fuertes J; Montagut C; Bullich S; Coma MI; Mestre-Fusco A; Suárez-Piñera M; Trampal C; Bellmunt J
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):95-101. PubMed ID: 25263718
[TBL] [Abstract][Full Text] [Related]
16. FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
Taghipour M; Wray R; Sheikhbahaei S; Wright JL; Subramaniam RM
AJR Am J Roentgenol; 2016 Apr; 206(4):846-55. PubMed ID: 27003053
[TBL] [Abstract][Full Text] [Related]
17. Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.
Baun C; Falch K; Gerke O; Hansen J; Nguyen T; Alavi A; Høilund-Carlsen PF; Hildebrandt MG
BMC Med Imaging; 2018 May; 18(1):11. PubMed ID: 29743027
[TBL] [Abstract][Full Text] [Related]
18. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
19.
Wang Z; Ma D; Yang J
Hell J Nucl Med; 2016; 19(3):241-244. PubMed ID: 27824963
[TBL] [Abstract][Full Text] [Related]
20. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
